drugset / Trial / NCT01484990

A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease

NCT01484990

Phase 1 Completed 19 enrolled AbbVie Quintiles, Inc. · collab
NaSingle-groupOpen-labelOther

Summary

A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects with Advanced Parkinson's Disease.

Timeline

Start
2010-04
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbidopa Unknown 395 mg Other
Subject Levodopa Small molecule 1580 mg Other

Indications